Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Wisconsin, Madison | OTHER |
| Massachusetts General Hospital | OTHER |
| University Hospitals Cleveland Medical Center | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
According to the peripheral trigger theory of migraine headaches, nociceptive inputs from irritated or compressed cranial nerve branches can lead to neurovascular changes in the brain that cause migraine headaches. Advanced treatments aimed at deactivating the peripheral trigger points can be administered to patients who have failed medical management of migraines. Those accepted advanced treatments include botulinum toxin A injection in order to temporarily paralyze muscles causing nerve compression, and surgery to release those compression points permanently. An advantage of surgery is the ability to release non-muscular causes of nerve compression, such as fascial bands or intersecting arteries.
Botulinum toxin A injection into trigger sites has been shown in multiple studies to be effective at reducing the frequency and severity of migraine headaches, and is a very commonly administered treatment for refractory migraines. It is approved by the FDA for the treatment of chronic migraines.
Similarly, surgical decompression of trigger sites has previously been shown to have superior clinical outcomes to medical management, through a randomized, blinded controlled-trial performed at Case Western Reserve in 2009. Patients either received actual decompression of the trigger sites, or sham surgery (exposure and visualization of the trigger sites, without decompression). At one-year follow-up, the group who underwent actual surgery demonstrated a statistically higher proportion with significant improvement in their migraines (83.7% vs. 57.7%, p=0.014), and with complete elimination of their migraines (57.1% vs. 3.8%, p<0.001). Several other reports have confirmed the good clinical outcomes of surgery demonstrated in this trial, and surgical decompression is now commonly performed by several surgeons around the United States.
Prognostic factors predicting the success of surgical decompression in migraine headache treatment include older age of migraine onset, visual symptoms/aura, and 4-site decompression. Factors predicting failure of surgery include excessive operative blood loss, and surgery on only one or two trigger sites.
One criticism of the studies on peripheral trigger decompression surgery for migraines has been that most of the results have originated from the same institution (Case Western Reserve), and from the same author (Guyuron). While several studies at other institutions have demonstrated positive outcomes of peripheral trigger decompression, these have only included a small number of patients.
In addition, the sham surgery randomized-controlled trial has been criticized for not clarifying any prior treatments that patients had undergone before peripheral trigger deactivation, and for not showing how medication use patterns changed after surgery. Another criticism of that study was the fact that patients were examined by neurologists before the study but not after the study, and that surgery was performed on some patients with episodic migraines, who are known to not benefit from botulinum toxin. It is unclear what migraine types are most likely to benefit from surgical decompression.
The investigators' goal is to perform a multi-center, prospective trial to demonstrate the effectiveness of peripheral trigger decompression in the treatment of migraine headaches, which would address the criticisms mentioned above. The main aim is to demonstrate that the positive results demonstrated by Guyuron et al are reproducible at other institutions and by other surgeons using similar techniques on different patient populations.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Botulinum toxin | Experimental | Patients in this arm will receive botulinum toxin for migraine headaches |
|
| Surgery | Experimental | Patients in this arm will receive surgery for migraine headaches |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Botulinum Toxin Type A | Drug |
| ||
| Surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Migraine Headache Index (MHI) at 1 Year | MHI is a numerical value calculated by multiplying the severity (1-10 numerical rating scale), duration (fraction of 24 h), and frequency (days per month) of migraine headaches. The lower the value the lower migraine severity reported is. The index range is minimum 0.00 to maximum 300.00. | 1 year postoperatively |
| Migraine Headache Index (MHI) at 2 Years | MHI is a numerical value calculated by multiplying the severity (1-10 numerical rating scale), duration (fraction of 24 h), and frequency (days per month) of migraine headaches. The lower the value the lower migraine severity reported is. The index range is minimum 0.00 to maximum 300.00. | 2 years postoperatively |
| Migraine Headache Index (MHI) at 2.5 Years | MHI is a numerical value calculated by multiplying the severity (1-10 numerical rating scale), duration (fraction of 24 h), and frequency (days per month) of migraine headaches. The lower the value the lower migraine severity reported is. The index range is minimum 0.00 to maximum 300.00. | 2.5 years postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Migraine Disability Assessment Test (MIDAS) Score at 1 Year | MIDAS questionnaire was developed to quantify the effect of headaches on patients' daily functionality in the past 3 months. It consists of five questions related to paid work or school, household work, and leisure time. A total score of 0-5 corresponds to little or no disability, 6-10 points refers to mild disability, 11-20 points mean moderate disability, and more than 21 points represent severe disability (MIDAS total). For MIDAS total, the higher the numeric response, the greater the overall impact of MH. The minimum score is 0.00 and the maximum score is 90.00. |
Not provided
Inclusion Criteria:
Patients with migraines related to a trigger site at the location of a branch of a cranial nerve (frontal, temporal, occipital)
Patients with chronic migraine (≥15 days per month) as dictated by the FDA indication for botulinum, and as diagnosed by a board-certified neurologist
Patients with episodic migraines
Patients who respond to diagnostic botulinum toxin injection or to a diagnostic anesthetic block
Patients who have failed 2 of 3 classes of preventative migraine medications
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Peled Plastic Surgery | San Francisco | California | 94118 | United States | ||
| Premier Plastic Surgery of Kansas City |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Botulinum Toxin | Patients in this arm will receive botulinum toxin for migraine headaches Botulinum Toxin Type A Daily headache diary Migraine Disability Assessment Test (MIDAS) Migraine Work and Productivity Loss Questionnaire (MWPLQ) Migraine-Specific Quality of Life Questionnaire (MSQ) |
| FG001 |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Feb 16, 2014 | Apr 9, 2024 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Daily headache diary | Other |
|
| Migraine Disability Assessment Test (MIDAS) | Other |
|
| Migraine Work and Productivity Loss Questionnaire (MWPLQ) | Other |
|
| Migraine-Specific Quality of Life Questionnaire (MSQ) | Other |
|
| 1 year postoperatively |
| Migraine Disability Assessment Test (MIDAS) Score at 2 Years | MIDAS questionnaire was developed to quantify the effect of headaches on patients' daily functionality in the past 3 months. It consists of five questions related to paid work or school, household work, and leisure time. A total score of 0-5 corresponds to little or no disability, 6-10 points refers to mild disability, 11-20 points mean moderate disability, and more than 21 points represent severe disability (MIDAS total). For MIDAS total, the higher the numeric response, the greater the overall impact of MH. The minimum score is 0.00 and the maximum score is 90.00. | 2 years postoperatively |
| Migraine Disability Assessment Test (MIDAS) Score at 2.5 Years | MIDAS questionnaire was developed to quantify the effect of headaches on patients' daily functionality in the past 3 months. It consists of five questions related to paid work or school, household work, and leisure time. A total score of 0-5 corresponds to little or no disability, 6-10 points refers to mild disability, 11-20 points mean moderate disability, and more than 21 points represent severe disability (MIDAS total). For MIDAS total, the higher the numeric response, the greater the overall impact of MH. The minimum score is 0.00 and the maximum score is 90.00. | 2.5 years postoperatively |
| Migraine Work and Productivity Loss Questionnaire (MMWPLQ) Score at 1 Year | MWPLQ has nine questions that evaluate the impact of migraine and migraine therapy on paid work and productivity loss. Question #7 from the MWPLQ (MWPLQ7) was the most frequently and consistently answered with meaningful responses and did not depend on questions #1-6, 8-9. Therefore, MWPLQ7 was analyzed independently, and the remaining questions were not included in the final analysis. Question #7 assesses the difficulty of 18 work-related activities caused by the most recent MH or migraine headache treatment. Each item in question 7 has the following options: 0 ('no difficulty'), 1 ('a slight amount'), 2 ('some'), 3 ('quite a bit'), 4 ('a great deal'), 5 ('so much difficulty, could not do at all'), and 6 ('does not apply to my work'). To quantify difficulty, a total sum score of these 18 items including only options 0 to 5 is obtained. A higher MWPLQ7 summed score reveals a higher (worse) effect of MH on work and productivity. The minimum is 0.00 and the maximum is 90.00 | 1 year postoperatively |
| Migraine Work and Productivity Loss Questionnaire (MMWPLQ) Score at 2 Years | MWPLQ has nine questions that evaluate the impact of migraine and migraine therapy on paid work and productivity loss. Question #7 from the MWPLQ (MWPLQ7) was the most frequently and consistently answered with meaningful responses and did not depend on questions #1-6, 8-9. Therefore, MWPLQ7 was analyzed independently, and the remaining questions were not included in the final analysis. Question #7 assesses the difficulty of 18 work-related activities caused by the most recent MH or migraine headache treatment. Each item in question 7 has the following options: 0 ('no difficulty'), 1 ('a slight amount'), 2 ('some'), 3 ('quite a bit'), 4 ('a great deal'), 5 ('so much difficulty, could not do at all'), and 6 ('does not apply to my work'). To quantify difficulty, a total sum score of these 18 items including only options 0 to 5 is obtained. A higher MWPLQ7 summed score reveals a higher (worse) effect of MH on work and productivity. The minimum is 0.00 and the maximum is 90.00 | 2 years postoperatively |
| Migraine Work and Productivity Loss Questionnaire (MMWPLQ) Score at 2.5 Years | MWPLQ has nine questions that evaluate the impact of migraine and migraine therapy on paid work and productivity loss. Question #7 from the MWPLQ (MWPLQ7) was the most frequently and consistently answered with meaningful responses and did not depend on questions #1-6, 8-9. Therefore, MWPLQ7 was analyzed independently, and the remaining questions were not included in the final analysis. Question #7 assesses the difficulty of 18 work-related activities caused by the most recent MH or migraine headache treatment. Each item in question 7 has the following options: 0 ('no difficulty'), 1 ('a slight amount'), 2 ('some'), 3 ('quite a bit'), 4 ('a great deal'), 5 ('so much difficulty, could not do at all'), and 6 ('does not apply to my work'). To quantify difficulty, a total sum score of these 18 items including only options 0 to 5 is obtained. A higher MWPLQ7 summed score reveals a higher (worse) effect of MH on work and productivity. The minimum is 0.00 and the maximum is 90.00 | 2.5 years postoperatively |
| Migraine-Specific Quality of Life Questionnaire (MSQ) Score at 1 Year | MSQ is a 14-item questionnaire that evaluates the long-term perceived impact of MH on health-related quality of life over the past 4 weeks. Responses per item include a 6-point scale: 'none of the time,' 'a little bit of the time,' 'some of the time,' 'a good bit of the time,' 'most of the time,' and 'all of the time.' Each option is assigned a score of 1 to 6, respectively. Each domain is scored independently as a sum of items and rescaled from a 0 to 100 scale, with higher scores indicating better quality of life. MSQ survey was analyzed in totality. A higher MSQ sum reflects patient improvement in quality of life. The minimum is 0.00 and the maximum is 270.00. | 1 year postoperatively |
| Migraine-Specific Quality of Life Questionnaire (MSQ) Score at 2 Years | MSQ is a 14-item questionnaire that evaluates the long-term perceived impact of MH on health-related quality of life over the past 4 weeks. Responses per item include a 6-point scale: 'none of the time,' 'a little bit of the time,' 'some of the time,' 'a good bit of the time,' 'most of the time,' and 'all of the time.' Each option is assigned a score of 1 to 6, respectively. Each domain is scored independently as a sum of items and rescaled from a 0 to 100 scale, with higher scores indicating better quality of life. MSQ survey was analyzed in totality. A higher MSQ sum reflects patient improvement in quality of life. The minimum is 0.00 and the maximum is 270.00. | 2 years postoperatively |
| Migraine-Specific Quality of Life Questionnaire (MSQ) Score at 2.5 Years | MSQ is a 14-item questionnaire that evaluates the long-term perceived impact of MH on health-related quality of life over the past 4 weeks. Responses per item include a 6-point scale: 'none of the time,' 'a little bit of the time,' 'some of the time,' 'a good bit of the time,' 'most of the time,' and 'all of the time.' Each option is assigned a score of 1 to 6, respectively. Each domain is scored independently as a sum of items and rescaled from a 0 to 100 scale, with higher scores indicating better quality of life. MSQ survey was analyzed in totality. A higher MSQ sum reflects patient improvement in quality of life. The minimum is 0.00 and the maximum is 270.00. | 2.5 years postoperatively |
| Olathe |
| Kansas |
| 66061 |
| United States |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States |
| Neuropax Clinic | St Louis | Missouri | 63161 | United States |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | United States |
| The University of Wisconsin-Madison | Madison | Wisconsin | 53792 | United States |
| Surgery |
Patients in this arm will receive surgery for migraine headaches Surgery Daily headache diary Migraine Disability Assessment Test (MIDAS) Migraine Work and Productivity Loss Questionnaire (MWPLQ) Migraine-Specific Quality of Life Questionnaire (MSQ) |
| COMPLETED |
|
| NOT COMPLETED |
|
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Botulinum Toxin | Patients in this arm will receive botulinum toxin for migraine headaches Botulinum Toxin Type A Daily headache diary Migraine Disability Assessment Test (MIDAS) Migraine Work and Productivity Loss Questionnaire (MWPLQ) Migraine-Specific Quality of Life Questionnaire (MSQ) |
| BG001 | Surgery | Patients in this arm will receive surgery for migraine headaches Surgery Daily headache diary Migraine Disability Assessment Test (MIDAS) Migraine Work and Productivity Loss Questionnaire (MWPLQ) Migraine-Specific Quality of Life Questionnaire (MSQ) |
| BG002 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants | Participants |
| ||||||||||||||||
| Age, Continuous | Mean | Standard Deviation | years |
| |||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
| |||||||||||||||
| Region of Enrollment | Number | participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Migraine Headache Index (MHI) at 1 Year | MHI is a numerical value calculated by multiplying the severity (1-10 numerical rating scale), duration (fraction of 24 h), and frequency (days per month) of migraine headaches. The lower the value the lower migraine severity reported is. The index range is minimum 0.00 to maximum 300.00. | Patients enrolled and analyzed in each group for this outcome measure. | Posted | Mean | 95% Confidence Interval | index score | 1 year postoperatively |
|
|
| ||||||||||||||||||||||||||||
| Primary | Migraine Headache Index (MHI) at 2 Years | MHI is a numerical value calculated by multiplying the severity (1-10 numerical rating scale), duration (fraction of 24 h), and frequency (days per month) of migraine headaches. The lower the value the lower migraine severity reported is. The index range is minimum 0.00 to maximum 300.00. | patients enrolled and analyzed in each group for this outcome measure. | Posted | Mean | 95% Confidence Interval | index score | 2 years postoperatively |
|
| |||||||||||||||||||||||||||||
| Primary | Migraine Headache Index (MHI) at 2.5 Years | MHI is a numerical value calculated by multiplying the severity (1-10 numerical rating scale), duration (fraction of 24 h), and frequency (days per month) of migraine headaches. The lower the value the lower migraine severity reported is. The index range is minimum 0.00 to maximum 300.00. | participants and enrolled and analyzed for this outcome measure | Posted | Mean | 95% Confidence Interval | index score | 2.5 years postoperatively |
|
| |||||||||||||||||||||||||||||
| Secondary | Migraine Disability Assessment Test (MIDAS) Score at 1 Year | MIDAS questionnaire was developed to quantify the effect of headaches on patients' daily functionality in the past 3 months. It consists of five questions related to paid work or school, household work, and leisure time. A total score of 0-5 corresponds to little or no disability, 6-10 points refers to mild disability, 11-20 points mean moderate disability, and more than 21 points represent severe disability (MIDAS total). For MIDAS total, the higher the numeric response, the greater the overall impact of MH. The minimum score is 0.00 and the maximum score is 90.00. | participants enrolled and analyzed in this outcome measure at this time point | Posted | Mean | 95% Confidence Interval | units on a scale | 1 year postoperatively |
| ||||||||||||||||||||||||||||||
| Secondary | Migraine Disability Assessment Test (MIDAS) Score at 2 Years | MIDAS questionnaire was developed to quantify the effect of headaches on patients' daily functionality in the past 3 months. It consists of five questions related to paid work or school, household work, and leisure time. A total score of 0-5 corresponds to little or no disability, 6-10 points refers to mild disability, 11-20 points mean moderate disability, and more than 21 points represent severe disability (MIDAS total). For MIDAS total, the higher the numeric response, the greater the overall impact of MH. The minimum score is 0.00 and the maximum score is 90.00. | participants enrolled and analyzed for this outcome at this timepoint | Posted | Mean | 95% Confidence Interval | units on a scale | 2 years postoperatively |
| ||||||||||||||||||||||||||||||
| Secondary | Migraine Disability Assessment Test (MIDAS) Score at 2.5 Years | MIDAS questionnaire was developed to quantify the effect of headaches on patients' daily functionality in the past 3 months. It consists of five questions related to paid work or school, household work, and leisure time. A total score of 0-5 corresponds to little or no disability, 6-10 points refers to mild disability, 11-20 points mean moderate disability, and more than 21 points represent severe disability (MIDAS total). For MIDAS total, the higher the numeric response, the greater the overall impact of MH. The minimum score is 0.00 and the maximum score is 90.00. | participants enrolled and analyzed in the outcome measure at the timepoint | Posted | Mean | 95% Confidence Interval | units on a scale | 2.5 years postoperatively |
| ||||||||||||||||||||||||||||||
| Secondary | Migraine Work and Productivity Loss Questionnaire (MMWPLQ) Score at 1 Year | MWPLQ has nine questions that evaluate the impact of migraine and migraine therapy on paid work and productivity loss. Question #7 from the MWPLQ (MWPLQ7) was the most frequently and consistently answered with meaningful responses and did not depend on questions #1-6, 8-9. Therefore, MWPLQ7 was analyzed independently, and the remaining questions were not included in the final analysis. Question #7 assesses the difficulty of 18 work-related activities caused by the most recent MH or migraine headache treatment. Each item in question 7 has the following options: 0 ('no difficulty'), 1 ('a slight amount'), 2 ('some'), 3 ('quite a bit'), 4 ('a great deal'), 5 ('so much difficulty, could not do at all'), and 6 ('does not apply to my work'). To quantify difficulty, a total sum score of these 18 items including only options 0 to 5 is obtained. A higher MWPLQ7 summed score reveals a higher (worse) effect of MH on work and productivity. The minimum is 0.00 and the maximum is 90.00 | participants enrolled and analyzed for this outcome measure at this timepoint | Posted | Mean | 95% Confidence Interval | units on a scale | 1 year postoperatively |
| ||||||||||||||||||||||||||||||
| Secondary | Migraine Work and Productivity Loss Questionnaire (MMWPLQ) Score at 2 Years | MWPLQ has nine questions that evaluate the impact of migraine and migraine therapy on paid work and productivity loss. Question #7 from the MWPLQ (MWPLQ7) was the most frequently and consistently answered with meaningful responses and did not depend on questions #1-6, 8-9. Therefore, MWPLQ7 was analyzed independently, and the remaining questions were not included in the final analysis. Question #7 assesses the difficulty of 18 work-related activities caused by the most recent MH or migraine headache treatment. Each item in question 7 has the following options: 0 ('no difficulty'), 1 ('a slight amount'), 2 ('some'), 3 ('quite a bit'), 4 ('a great deal'), 5 ('so much difficulty, could not do at all'), and 6 ('does not apply to my work'). To quantify difficulty, a total sum score of these 18 items including only options 0 to 5 is obtained. A higher MWPLQ7 summed score reveals a higher (worse) effect of MH on work and productivity. The minimum is 0.00 and the maximum is 90.00 | participants enrolled and analyzed for this outcome measure at this timepoint | Posted | Mean | 95% Confidence Interval | units on a scale | 2 years postoperatively |
| ||||||||||||||||||||||||||||||
| Secondary | Migraine Work and Productivity Loss Questionnaire (MMWPLQ) Score at 2.5 Years | MWPLQ has nine questions that evaluate the impact of migraine and migraine therapy on paid work and productivity loss. Question #7 from the MWPLQ (MWPLQ7) was the most frequently and consistently answered with meaningful responses and did not depend on questions #1-6, 8-9. Therefore, MWPLQ7 was analyzed independently, and the remaining questions were not included in the final analysis. Question #7 assesses the difficulty of 18 work-related activities caused by the most recent MH or migraine headache treatment. Each item in question 7 has the following options: 0 ('no difficulty'), 1 ('a slight amount'), 2 ('some'), 3 ('quite a bit'), 4 ('a great deal'), 5 ('so much difficulty, could not do at all'), and 6 ('does not apply to my work'). To quantify difficulty, a total sum score of these 18 items including only options 0 to 5 is obtained. A higher MWPLQ7 summed score reveals a higher (worse) effect of MH on work and productivity. The minimum is 0.00 and the maximum is 90.00 | participants enrolled and analyzed for this outcome measure during this timepoint | Posted | Mean | 95% Confidence Interval | units on a scale | 2.5 years postoperatively |
| ||||||||||||||||||||||||||||||
| Secondary | Migraine-Specific Quality of Life Questionnaire (MSQ) Score at 1 Year | MSQ is a 14-item questionnaire that evaluates the long-term perceived impact of MH on health-related quality of life over the past 4 weeks. Responses per item include a 6-point scale: 'none of the time,' 'a little bit of the time,' 'some of the time,' 'a good bit of the time,' 'most of the time,' and 'all of the time.' Each option is assigned a score of 1 to 6, respectively. Each domain is scored independently as a sum of items and rescaled from a 0 to 100 scale, with higher scores indicating better quality of life. MSQ survey was analyzed in totality. A higher MSQ sum reflects patient improvement in quality of life. The minimum is 0.00 and the maximum is 270.00. | participants enrolled and analyzed during this timepoint for this outcome | Posted | Mean | 95% Confidence Interval | units on a scale | 1 year postoperatively |
| ||||||||||||||||||||||||||||||
| Secondary | Migraine-Specific Quality of Life Questionnaire (MSQ) Score at 2 Years | MSQ is a 14-item questionnaire that evaluates the long-term perceived impact of MH on health-related quality of life over the past 4 weeks. Responses per item include a 6-point scale: 'none of the time,' 'a little bit of the time,' 'some of the time,' 'a good bit of the time,' 'most of the time,' and 'all of the time.' Each option is assigned a score of 1 to 6, respectively. Each domain is scored independently as a sum of items and rescaled from a 0 to 100 scale, with higher scores indicating better quality of life. MSQ survey was analyzed in totality. A higher MSQ sum reflects patient improvement in quality of life. The minimum is 0.00 and the maximum is 270.00. | participants enrolled and analyzed for this outcome measure at this timepoint | Posted | Mean | 95% Confidence Interval | units on a scale | 2 years postoperatively |
| ||||||||||||||||||||||||||||||
| Secondary | Migraine-Specific Quality of Life Questionnaire (MSQ) Score at 2.5 Years | MSQ is a 14-item questionnaire that evaluates the long-term perceived impact of MH on health-related quality of life over the past 4 weeks. Responses per item include a 6-point scale: 'none of the time,' 'a little bit of the time,' 'some of the time,' 'a good bit of the time,' 'most of the time,' and 'all of the time.' Each option is assigned a score of 1 to 6, respectively. Each domain is scored independently as a sum of items and rescaled from a 0 to 100 scale, with higher scores indicating better quality of life. MSQ survey was analyzed in totality. A higher MSQ sum reflects patient improvement in quality of life. The minimum is 0.00 and the maximum is 270.00. | participants enrolled and analyzed at this outcome measure at this timepoint | Posted | Mean | 95% Confidence Interval | units on a scale | 2.5 years postoperatively |
|
2.5 years
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Botulinum Toxin | Patients in this arm will receive botulinum toxin for migraine headaches Botulinum Toxin Type A Daily headache diary Migraine Disability Assessment Test (MIDAS) Migraine Work and Productivity Loss Questionnaire (MWPLQ) Migraine-Specific Quality of Life Questionnaire (MSQ) | 0 | 11 | 0 | 11 | 0 | 11 |
| EG001 | Surgery | Patients in this arm will receive surgery for migraine headaches Surgery Daily headache diary Migraine Disability Assessment Test (MIDAS) Migraine Work and Productivity Loss Questionnaire (MWPLQ) Migraine-Specific Quality of Life Questionnaire (MSQ) | 0 | 33 | 0 | 33 | 0 | 33 |
Not provided
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Jeffrey Janis | The Ohio State University | (614) 293-8566 | jeffrey.janis@osumc.edu |
| Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | Feb 16, 2014 | Apr 9, 2024 | SAP_001.pdf |
| ID | Term |
|---|---|
| D008881 | Migraine Disorders |
| ID | Term |
|---|---|
| D051270 | Headache Disorders, Primary |
| D020773 | Headache Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019274 | Botulinum Toxins, Type A |
| D013514 | Surgical Procedures, Operative |
| ID | Term |
|---|---|
| D001905 | Botulinum Toxins |
| D008666 | Metalloendopeptidases |
| D010450 | Endopeptidases |
| D010447 | Peptide Hydrolases |
| D006867 | Hydrolases |
| D004798 | Enzymes |
| D045762 | Enzymes and Coenzymes |
| D045726 | Metalloproteases |
| D001426 | Bacterial Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D001427 | Bacterial Toxins |
| D014118 | Toxins, Biological |
| D001685 | Biological Factors |
Not provided
Not provided
| Between 18 and 65 years |
|
| >=65 years |
|
|
|
|
|
|
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
Patients in this arm will receive surgery for migraine headaches Surgery Daily headache diary Migraine Disability Assessment Test (MIDAS) Migraine Work and Productivity Loss Questionnaire (MWPLQ) Migraine-Specific Quality of Life Questionnaire (MSQ) |
|
|
Patients in this arm will receive surgery for migraine headaches Surgery Daily headache diary Migraine Disability Assessment Test (MIDAS) Migraine Work and Productivity Loss Questionnaire (MWPLQ) Migraine-Specific Quality of Life Questionnaire (MSQ) |
|
|
Patients in this arm will receive surgery for migraine headaches Surgery Daily headache diary Migraine Disability Assessment Test (MIDAS) Migraine Work and Productivity Loss Questionnaire (MWPLQ) Migraine-Specific Quality of Life Questionnaire (MSQ) |
|
|
|
|
|
|
|
|